Differential prolactin response to oral metoclopramide in nulliparous versus parous women throughout the menstrual cycle

A. Espinosa de los Monteros, Antonio Espinosa de los Monteros, Judith Cornejo, Adalberto Parra
In: Fertility and Sterility · 1991 · vol. 55(5) , pp. 885–889 · doi:10.1016/s0015-0282(16)54293-9 · PMID:2022267 · W2405746338
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher

Abstract

ObjectiveTo analyze if serum prolactin (PRL) changed throughout the menstrual cycle and if parous women have lower PRL than nulliparous women.DesignA prospective study of PRL was performed in basal conditions and during oral metoclopramide stimulation on days 7, 14, and 21 of menstrual cycle.SettingInstituto Nacional de Perinatología, third level medical institution.PatientsFour parous (group A) and seven nulliparous (group B) healthy volunteer women entered and finished the study.InterventionsWomen were studied each day before and every 30 minutes during 2 hours after oral metoclopramide (10 mg).Main outcome measureDuplicate PRL determinations were performed by radioimmunoanalysis. Hypothesis was formulated before data collection.ResultsGroup A and B had similar basal PRL levels and no within group differences existed in response to metoclopramide, regardless of the day studied. Group A had lower PRL increments than group B from 60 to 120 minutes on days 14 and 21 (P less than 0.05); the peak increments also were lower on days 7, 14, and 21 (P less than 0.05).ConclusionsParous women had a diminished PRL response. Although the dopaminergic tone was similar throughout the menstrual cycle within each group, two distinct levels of dopaminergic tone existed in parous and nulliparous women.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

References (10)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-14T06:18:11.163272+00:00
unpaywall
last seen: 2026-08-20T06:30:07.000247+00:00
License: CC0 · commercial use OK